Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1082 | 1083 | (Page 1084) | 1085 | 1086 | .... | 1118 | newer

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) Glycated Hemoglobin Testing Solutions Industry 2018 Market Research report gives estimation of the factors that are boosting the development of the Glycated Hemoglobin Testing Solutions market and it also gives the analytical data of Market Size, Share, Growth, Application, Opportunity analysis, and forecast on the basis of key principles segments such as end-users, application, product, technology, and region are surveyed comprehensively.

    Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average because the lifespan of a red blood cell is four months (120 days). However, since red blood cells do not all undergo lysis at the same time, HbA1C is taken as a limited measure of three months. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose.

    Get Free Sample Copy of Report https://www.researchformarkets.com/sample/global-glycated-hemoglobin-testing-market-201857
    The following manufacturers are covered in this report:
    • Abbott
    • Bio-Rad Laboratories
    • Danaher
    • EKF Diagnostics
    • F. Hoffmann-La Roche

    Market Segment by Regions, regional analysis covers
    • North America (United States, Canada and Mexico)
    • Europe (Germany, France, UK, Russia and Italy)
    • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • South America (Brazil, Argentina, Colombia)
    • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    • Lab Based Test
    • Point-of-Care Test

    Market Segment by Applications, can be divided into
    • Hospitals
    • Clinics
    • Diagnostic Laboratories
    • Academic and Research Institutes

    Get More Information about this report https://www.researchformarkets.com/reports/global-glycated-hemoglobin-testing-market-201857

    Table of Content:

    1 Glycated Hemoglobin Testing Market Overview
    2 Manufacturers Profiles
    3 Global Glycated Hemoglobin Testing Market Competition, by Players
    4 Global Glycated Hemoglobin Testing Market Size by Regions
    5 North America Glycated Hemoglobin Testing Revenue by Countries
    6 Europe Glycated Hemoglobin Testing Revenue by Countries
    7 Asia-Pacific Glycated Hemoglobin Testing Revenue by Countries
    8 South America Glycated Hemoglobin Testing Revenue by Countries
    9 Middle East and Africa Revenue Glycated Hemoglobin Testing by Countries
    10 Global Glycated Hemoglobin Testing Market Segment by Type
    11 Global Glycated Hemoglobin Testing Market Segment by Application
    12 Global Glycated Hemoglobin Testing Market Size Forecast (2018-2023)
    13 Research Findings and Conclusion
    14 Appendix

    Note: If you have any special requirements, please let us know and we will offer you the report as you want.

    Reasons to Purchase this Report:
    •Current and future of global Glycated Hemoglobin Testing market outlook in the developed and emerging markets
    •The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
    •Regions/countries that are expected to witness the fastest growth rates during the forecast period
    •The latest developments, market shares, and strategies that are employed by the major market players

    The report provides insights on the following pointers:
    1. Learn about the market strategies that are being adopted by your competitors and leading organizations
    2. Market Penetration: Comprehensive information on the product portfolios of the top players in the trocars market
    3. To gain insightful analyses of the market and have a comprehensive understanding of the “Xyz” and its commercial landscape
    4. Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the trocars market
    5. To understand the future outlook and prospects for Xyz market analysis and forecast 2018-2025.
    6. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the trocars market

    Request For Discount at https://www.researchformarkets.com/discount/global-glycated-hemoglobin-testing-market-201857

    Scope of the Report:

    •This report studies the Glycated Hemoglobin Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glycated Hemoglobin Testing market by product type and applications/end industries.
    •High prevalence rate coupled with increasing incidence of diabetes among individuals in developed and developing economies are major factors driving growth of the global glycated hemoglobin testing market. In addition, growing awareness among diabetics for early diagnosis of diabetes so as to help in treatment & management of diabetes is another factor fueling growth of the global glycated hemoglobin testing market.
    •A major and rising trend in the global glycated hemoglobin testing market is increasing adoption of point-of-care testing for glycated hemoglobin testing by individuals across developed and in some developing economies. Access to results in substantially less amount of time as compared to that of lab based tests is a major factor for this increasing adoption.
    •The Americas will be the major revenue contributor to the hemoglobin A1C test throughout the forecast period. FActors such as the rising prevalence of diabetes and similar diseases, will fuel the steady growth of the market in this region.
    •The global Glycated Hemoglobin Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
    •The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
    •North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glycated Hemoglobin Testing.
    •Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

    Purchase This Report at https://www.researchformarkets.com/buy-now/global-glycated-hemoglobin-testing-market-201857/one

    Contact Info:
    Name: Research For Markets
    Email: alan.naidu@researchformarkets.com
    Phone: +44 8000-4182-37


    Mr. A Naidu
    +1-888-387-2818
    alan.naidu@researchformarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) Infection control is the discipline concerned with preventing nosocomial or healthcare-associated infection. Infection control addresses factors related to the spread of infections within the healthcare setting (whether patient-to-patient, from patients to staff and from staff to patients, or among-staff), including prevention (via hand hygiene/hand washing, cleaning/disinfection/sterilization, vaccination, surveillance), monitoring/investigation of demonstrated or suspected spread of infection within a particular health-care setting (surveillance and outbreak investigation), and management (interruption of outbreaks).
    Anti-infective agents include antibiotics, antibacterials, antifungals, antivirals and antiprotozoals.
    Over the next five years, Expert projects that Infection Control and Biosafety Products will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-58608


    This report presents a comprehensive overview, market shares and growth opportunities of Infection Control and Biosafety Products market by product type, application, key companies and key regions.

    To calculate the market size, Expert considers value generated from the sales of the following segments:
    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
    3M
    Reckitt Benckiser
    BODE Chemie
    STERIS
    Thermo Fisher Scientific
    ABC Compounding
    American Biotech Labs
    Baxter
    Bio-Cide International
    CareFusion
    Ecolab
    Hemco Corporation
    Kewaunee
    Labconco
    Metrex Research
    The Baker Company
    The Clorox Company
    Terra Universal

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-58608

    Segmentation by product type:
    Biosafety products
    Infection control products
    Segmentation by application:
    Children
    Adults
    Senior Citizens
    Foreigners

    We can also provide the customized separate regional or country-level reports, for the following regions:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    Buy now@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-58608/



    Research objectives
    To study and analyze the global Infection Control and Biosafety Products market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Infection Control and Biosafety Products market by identifying its various subsegments.
    Focuses on the key global Infection Control and Biosafety Products players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Infection Control and Biosafety Products with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the size of Infection Control and Biosafety Products submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.



    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
    Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
    Over the next five years, Expert projects that Infectious Disease Diagnostics Testing will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    Request Free Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-58609


    This report presents a comprehensive overview, market shares and growth opportunities of Infectious Disease Diagnostics Testing market by product type, application, key companies and key regions.
    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
    Abbott Diagnostic
    Alere
    bioMérieux
    Diasorin
    Roche Diagnostic
    Beckman Coulter
    Becton, Dickinson and Company
    Bio-Rad Laboratories
    Cavidi
    Cepheid
    Corgenix
    Diaxonhit
    Eiken Chemical
    EMD Millipore
    Epitope Diagnostic
    EUROIMMUN
    Gold Standard Diagnostics
    Hologic
    Immunetics
    InBios International

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.


    Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-58609

    To calculate the market size, Expert considers value generated from the sales of the following segments:

    Segmentation by product type:
    Molecular diagnostic test
    POC infectious disease diagnostics test
    Segmentation by application:
    Respiratory
    HIV
    HAIs
    Sexual health
    Tropical diseases
    Liver

    We can also provide the customized separate regional or country-level reports, for the following regions:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    Enquiry for Customization@ https://www.qurateresearch.com/report/customize/HnM/QBI-LPI-HnM-58609



    Research objectives
    To study and analyze the global Infectious Disease Diagnostics Testing market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Infectious Disease Diagnostics Testing market by identifying its various subsegments.
    Focuses on the key global Infectious Disease Diagnostics Testing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Infectious Disease Diagnostics Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the size of Infectious Disease Diagnostics Testing submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.



    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Dental liners Market Report for 2018-2023.
    A dental liner is a material that is usually placed in a thin layer over exposed dentine within a cavity preparation. Its functions are dentinal sealing, pulpal protection, thermal insulation and stimulation of the formation of irregular secondary (tertiary) dentine.
    Over the next five years, Expert projects that Dental liners will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    This report presents a comprehensive overview, market shares, and growth opportunities of Dental liners market by product type, application, key manufacturers and key regions.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-58982

    To calculate the market size, Expert considers value and volume generated from the sales of the following segments:

    Segmentation by product type:
    Glass ionomer
    Calcium hydroxide
    Segmentation by application:
    Hospital
    Dental clinic

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-58982

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    3M
    Vigodent
    Willmann & Pein GmbH
    VOCO GmbH
    GC America
    Temrex Corp.
    ...

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Dental liners consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Dental liners market by identifying its various subsegments.
    Focuses on the key global Dental liner’s manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Dental liners with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Direct Purchase@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-58982/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 17, 2018 ) According to the new market research report "Computer Assisted Coding Market by Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), Application (Automated Encoding, Clinical Coding Audit, Management Reporting) - Global Forecast to 2022", published by MarketsandMarkets™, The global computer-assisted coding market is valued at USD 2.76 Billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 Billion by 2022.

    Don’t miss out on business opportunities in Computer Assisted Coding Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2PpWcXm

    The global computer-assisted coding market is valued at USD 2.76 billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 billion by 2022. The growth of the market can be attributed to the transition to ICD-10 coding standards from ICD-9 in North America, the growing demand for CAC solutions, the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue cycle management procedures. The computer-assisted coding market is expanding with the emergence of new products and applications. These computer assisted coding solutions being used in many applications such as automated computer-assisted encoding, management reporting & analytics, and clinical coding auditing. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

    Market Dynamics

    Drivers

    Growing adoption of CAC solutions in North America due to the implementation of ICD-10 standards
     Increasing implementation of EHR systems
     Increasing utilization of CAC solutions to curtail the rising healthcare costs
     Growing regulatory requirements for patient data management
     Growing focus on physician computer-assisted coding in outpatient settings
    Restraints

    High implementation and maintenance costs
    Lack of on-site CAC support and in-house CAC domain knowledge
    Opportunities

    Untapped emerging markets
    Natural language processing-enabled CAC solutions
    Growing adoption of cloud-based solutions
    Challenge

    Reluctance to adopt CAC solutions among healthcare providers in emerging markets
    Browse and in-depth TOC on " Computer Assisted Coding Market "

    202 - Tables

    40 - Figures

    242 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/computer-assisted-coding-market-170644018.html

    The computer assisted coding market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the computer assisted coding market are 3M Health Information Systems (US), Optum (US), McKesson Corporation (US), Nuance Communications (US), Cerner Corporation (US), Dolbey Systems (US), Precyse Solutions (nThrive) (US), Craneware (UK), Artificial Medical Intelligence (US), and TruCode (US). Other players include Quest Diagnostics (US), Streamline Health Solutions (US), M-scribe Technologies (US), eZDI Inc. (US), Alpha II LLC. (US), ID GmbH & Co. KGaA (Germany), ZyDoc (US), Coding Strategies (US), Patient Code Software (US), and Flash Code (US) among others.

    Major Market Developments

    3M Company (US) launched the 3M 360 Encompass System – Professional computer assisted coding software in 2016.
    3M Company (US) acquired Semfinder (Switzerland), a medical coding technology company, provided 3M with important new coding technology to help accelerate the availability of the 3M 360 Encompass System in countries adopting electronic medical records in 2016.
    In 2016, Optum (US) collaborated with Quest Diagnostics (US), a provider of diagnostic information services, to deliver improved health systems solutions to all segments of the healthcare marketplace.
    Request for Free Sample Report @ http://bit.ly/2QBzoUE

    Browse Adjacent Markets @ Healthcare IT Market Research Reports & Consulting

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


    Contact:

    Mr. Shelly Singh

    MarketsandMarkets™ INC.
    630 Dundee Road

    Suite 430

    Northbrook, IL 60062

    USA : 1-888-600-6441

    Email: mailto:sales@marketsandmarkets.com
    Research Insight: https://www.marketsandmarkets.com/ResearchInsight/computer-assisted-coding-market.asp

    Visit Our Website: https://www.marketsandmarkets.com/


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) This study categorizes the global Enteral Feeding Tube breakdown data by manufacturers, region, type and application. It also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities & challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. As per this report Global Enteral Feeding Tube market size will increase to XX Million US$ by 2025, from XX Million US$ in 2017, at a CAGR of XX% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Enteral Feeding Tube.
    Access More Details about this Report at: https://www.themarketreports.com/report/global-enteral-feeding-tube-market-insights-forecast-to-2025

    Key companies profiled in Global Enteral Feeding Tube Market Report are Abbott, Fresenius Kabi, Danone, Nestle, Halyard Health, Cook Medical, B. Braun, Boston Scientific, Vygon, Conmed, C. R. Bard, Cardinal Health, Applied Medical and more in terms of capacity, production, value, price and market share of Enteral Feeding Tube in global market.
    Enteral Feeding Tube Breakdown Data by Type
    • Gastrostomy Tube
    • Nasoenteric Tube
    • Other
    Enteral Feeding Tube Breakdown Data by Application
    • Oncology
    • Gastroenterology
    • Neurology
    • Diabetes
    • Other
    Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/1303139

    Table of Contents
    1 Study Coverage
    2 Executive Summary
    3 Market Size by Manufacturers
    4 Enteral Feeding Tube Production by Regions
    5 Enteral Feeding Tube Consumption by Regions
    6 Market Size by Type
    7 Market Size by Application
    8 Manufacturers Profiles
    9 Production Forecasts
    10 Consumption Forecast
    11 Upstream, Industry Chain and Downstream Customers Analysis
    12 Opportunities & Challenges, Threat and Affecting Factors
    13 Key Findings
    14 Appendix
    Inquire for more details about this report at: https://www.themarketreports.com/report/ask-your-query/1303139


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 17, 2018 ) According to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The Synthetic Biology Market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%. 

    Don’t miss out on business opportunities in Synthetic Biology Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2Aby8m5
    The synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application. The pharmaceuticals subsegment is expected to account for the largest share of the market. However, biofuel and renewable energy is expected to grow at the highest CAGR during the forecast period owing to the global demand for fossil fuel alternatives and the advantages of the genetically engineered organisms for the synthetic production of biofuels.

    Research Methodology

    Top-down and bottom-up approaches were used to validate the size of the synthetic biology market and estimate the size of other dependent submarkets. Various secondary sources such as Centre for Synthetic Biology and Innovation (CSynBI), Institute of Systems and Synthetic Biology, University of California San Francisco (UCSF) Center for Systems & Synthetic Biology, Synthetic Biology Leadership Council (SBLC), Synthetic Biology Advisory Committee, Synthetic Biology Engineering Research Center (SynBERC), Industry Association of Synthetic Biology (IASB), European association of synthetic biology, Society for Biological Engineering (SBE), Systems and Synthetic Biology Journal, Biological Sciences Research Council, expert interviews, and MarketsandMarkets Analysishave been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

    Browse and in-depth TOC on “Synthetic Biology Market”
    162 - Tables

    32 - Figures

    214 - Pages                       

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html

    The US is expected to dominate the synthetic biology market in 2017

    In 2017, the US is estimated to account for the largest share among other regions in the synthetic biology market, followed by the UK and Germany. The dominant share of the US is attributed to factors such as increased demand for bio-based products, increased investments in synthetic biology companies, and rising R&D funding for synthetic biology.

    Based on region, the synthetic biology market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America is estimated to account for the largest share of the global market. Regarding growth rate, Europe is expected to register the highest growth rate from 2017 to 2022. Factors such as increasing investments for the adoption of adoption of novel synthetic biology technologies, rising R&D funding and collaborations are driving the growth of the market in this region.

    While the overall market is expected to grow at a high rate, possible environmental and security issues related to synthetic biology is likely to restrain the growth of this market to a certain extent.

    The major players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), among others.

    Request for Free Sample Report @ http://bit.ly/2Abtap3

    Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting
    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh

    MarketsandMarkets™ INC.
    630 Dundee Road

    Suite 430

    Northbrook, IL 60062

    USA : 1-888-600-6441

    Email: sales@marketsandmarkets.com
    Research Insight: https://www.marketsandmarkets.com/ResearchInsight/synthetic-biology-market.asp

    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 17, 2018 ) According to the new market research report "Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User (Hospitals) - Global Forecast to 2023", The immunoassay market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%.

    Don’t miss out on business opportunities in qPCR Reagents Market. Speak to our analyst and gain crucial industry insights that will help your business grow:
    https://www.marketsandmarkets.com/speaktoanalyst.asp?id=436
    The increasing incidence of chronic and infectious diseases, technological advancements in immunoassay instruments and introduction of novel automated systems, and growth in the biotechnology and biopharmaceutical industries are some the major factors driving the growth of this market.
    By product and service, the reagents and kits segment commanded the largest share of the market in 2017
    On the basis product and service, this market is classified into reagents and kits, analyzers, and software and services. In 2017, the reagents and kits segment accounted for the largest share of the immunoassays market. The large share of this segment can primarily be attributed to the requirement of the repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases.
    Download Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=436
    The chemiluminescence immunoassays (CLIAs) segment led the immunoassays market in 2017
    By platform, this market is classified into CLIAs, radioimmunoassays (RIAs), colorimetric immunoassays (CIs), fluorescence immunoassays (FIAs), and other platforms. The CLIAs segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment can primarily be attributed to the low cost and high sensitivity of CLIA-based tests.
    By technology, the enzyme-linked immunosorbent assays (ELISA) segment accounted for the largest share of the market in 2017
    On the basis of technology, the immunoassays market is segmented into ELISA, rapid tests, western blotting, enzyme-linked immunospot (ELISPOT), immuno-PCR, and other immunoassay technologies. The ELISA segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment can primarily be attributed to the increasing use of immunoassay tests in cancer, infectious diseases, and therapeutic drug level monitoring.
    Browse and in-depth TOC on “Immunoassay Market”
    293 - Tables
    50 - Figures
    344 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html
    North America held the largest share of the market in 2017
    Based on region, the immunoassay market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2017. The large share of this regional segment is attributed to the increasing incidence of chronic diseases and improved healthcare infrastructure.
    Key players in the immunoassays market include Roche (Switzerland), Abbott Laboratories (US), Siemens (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), bioMérieux (France), Ortho Clinical Diagnostics (US), DiaSorin (Italy), QIAGEN (Netherlands), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), PerkinElmer (US), Quidel Corporation (US), Bio-Techne Corporation (US), and Mindray (China).
    Research Insight: https://www.marketsandmarkets.com/ResearchInsight/immunoassay-market.asp

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    newsletter@marketsandmarkets.com



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) Global Follow-on Biologics Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Follow-on Biologics. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Follow-on Biologics market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Follow-on Biologics Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-follow-on-biologics-market-research-report-2018

    With this Follow-on Biologics Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Sandoz, Pfizer, Teva Pahrmaceutical, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy's Laboratories, Stada Arzneimittel Ag and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1060229

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Follow-on Biologics Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1060229

    List of Chapters:
    1 Follow-on Biologics Market Overview
    2 Global Follow-on Biologics Market Competitions by Manufacturers
    3 Global Follow-on Biologics Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Follow-on Biologics Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Follow-on Biologics Production, Revenue (Value), Price Trend by Type
    6 Global Follow-on Biologics Market Analysis by Application
    7 Global Follow-on Biologics Manufacturers Profiles/Analysis
    8 Follow-on Biologics Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Follow-on Biologics Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) The Global Halitosis Treatment Market, by Type (Pathological and Non-pathological), by Treatment (Antacids, Antiseptics, Antiplaque, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 7.2 billion in 2017, and is projected to exhibit a CAGR of 10.5% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

    Halitosis or bad breath according to a National Center for Biotechnology Information (NCBI), affect half of the population in the U.S. and between 50% and 60% of the population in France. Although it occurs due to number of causes, oral hygiene is a major factor. Respiratory system problems, hepatic disease, gastrointestinal disease, hematological or endocrine system disorders, and metabolic conditions can also the cause halitosis.

    Request a Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/2219

    Other potential factors that contribute to halitosis are endodontic, surgical, and pathologic factors such as exposed tooth pulps and non-vital tooth with fistula draining into the mouth, oral cancer, oral cavity pathologies, and ulcerations, extractions/healing wounds or prosthetics. All these factors cause food or plaque retention area, decay of amino acids, raising bacterial amount, tissue breakdown, and decreasing of saliva flow. These conditions result in the release of volatile compounds causing halitosis.

    Treatment for bad breath can vary depending on the cause. For instance, halitosis caused due to a buildup of bacteria (plaque) on teeth can be treated with mouth rinse that kills the bacteria. Furthermore, halitosis caused due to gum diseases can be treated with tooth cleaning procedures.

    Manufacturers in halitosis treatment market are focused on development and approval of new products and strategic collaborations with other industry players to gain significant market share. For instance, in 2017, Listerine, a leading market player in halitosis treatment market launched a new Green Tea variant that combines essential oils and green tea extract with fluoride.

    Browse 19 Market Data Tables and 23 Figures spread through 155 Pages and in-depth TOC on "Halitosis Treatment Market, by Type (Pathological and Non-pathological), by Treatment (Antacids, Antiseptics, Antiplaque, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

    To know the latest trends and insights related to halitosis treatment market, click the link below:
    https://www.coherentmarketinsights.com/market-insight/halitosis-treatment-market-2219

    Key Takeaways of the Halitosis Treatment Market:

    The global halitosis treatment market is expected to expand at a CAGR of 10.5% during the forecast period (2018–2026), owing to increasing occurrence of halitosis due various factors such as increasing consumption of tobacco, alcohol and sugary foods, and prevalence of various gastrointestinal diseases and infection of nose and throat.
    Among region, the Asia Pacific is expected witness growth at highest rate during the forecast period, owing to increasing awareness among population about oral hygiene.
    Major players operating in the global halitosis treatment market include Abbott Laboratories, AstraZeneca Plc., Colgate-Palmolive Company, Dr. Harold Katz, Listerine, and Rowpar Pharmaceuticals


    Pareesh Phulkar
    8087996871
    pareesh@coherentmarketinsights.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 17, 2018 ) The Global Avascular Necrosis Market, by Type (Trauma Related Avascular Necrosis, and Non-Trauma Related Avascular Necrosis), by Treatment (Drug-based and Surgery- based (Core Decompression Surgery, Osteotomy, Bone Graft, and Total Joint Replacement)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 512.9 million in 2017, and is projected to exhibit a CAGR of 6.0% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

    Request a Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/2218

    Avascular necrosis is a condition that results when blood flow to the head of thighbone is reduced or stopped, which leads to death of cells of bone tissue. There is no known pharmaceutical cure for permanent cure of avascular necrosis. Several combinations of non-operative treatments are used to reduce symptomatic pain such as electrical stimulation, hyperbaric oxygen therapy, shock wave therapy, physiotherapy, pharmaceuticals (such as bisphosphonates, anticoagulants, vasodilators, and lipid lowering agents), and muscle strengthening exercises. Operative treatments for avascular necrosis include core decompression, osteotomies, bone and cartilage grafting, and total hip replacement surgery. Biopsy is a conclusive way to diagnose avascular necrosis but is rarely used as it requires surgery.

    Recovery and rehabilitation of avascular necrosis depends on surgical treatment used. For instance, core decompression usually requires patients to use crutches for several weeks, while the recovery period for a bone graft used in combination with decompression is much longer. Osteotomies limit activity for few months, however, a total hip replacement allows patients to begin walking with support, within days.

    Browse 17 Market Data Tables and 21 Figures spread through 147 Pages and in-depth TOC on "Avascular Necrosis Market, by Type (Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis), by Treatment (Drug Based, Surgery Based {Core Decompression Surgery, Osteotomy, Bone Graft, And Total Joint Replacement}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

    To know the latest trends and insights related to avascular necrosis market, click the link below:
    https://www.coherentmarketinsights.com/market-insight/avascular-necrosis-market-2218

    Early diagnosis and treatment are essential for delaying disease progression and minimizing the need for costly and invasive procedures in avascular necrosis patients. According to Chinese Medical Journal 2015 study, direct cost to patients for undergoing primary total hip arthroplasty per hip without revision is between US$ 8000 and US$ 10,000 in China. Manufacturers in avascular necrosis market majorly focus on developing effective and inexpensive therapies for treating the disease. For instance, Bone Therapeutics and Enzo Biochem, Inc. focuses on gene regulation and cell-based product treatment, which is expected to increase avascular necrosis market revenue.

    Key Takeaways of the Avascular Necrosis Market:

    The global avascular necrosis market is expected to surge at a CAGR of 6.0% during the forecast period (2018–2026), owing to high prevalence of avascular necrosis coupled with the development of new therapies to treat the disease. According to the National Organization for Rare Disorders 2015 data, avascular necrosis is one of the rare diseases and affects one in 2000 people.
    Among region, Asia Pacific is expected to witness the highest rate of growth during the forecast period, owing to high prevalence of non-traumatic avascular necrosis of femoral head. According to Clinical Orthopedics and Related Research, 2010, in Japan about 2500–3300 new cases of non-traumatic avascular necrosis of the femoral head are reported annually, while around 11,400 patients were found to have sought treatment in 2004.
    Major players operating in the global avascular necrosis market include Bone Therapeutics, Boehringer Ingelheim GmbH, Bayer AG, Enzo Biochem Inc., Ethicon Inc., Eli Lilly and Company, Grifols SA, Integra LifeSciences Corporation, K-Stemcell Co Ltd., Medtronic Plc, Merck KGaA, Pfizer Inc., Sanofi SA, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings.


    Pareesh Phulkar
    8087996871
    pareesh@coherentmarketinsights.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) The Global Tissue Engineering Market, by Material Type (Synthetic, Biological, and Others), by Application (Dermal, Orthopedic, Dental, Neurology, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 5.5 billion in 2017, and is projected to exhibit a CAGR of 11.5% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

    Various diseases, injury, and trauma can lead to degeneration and damage of tissues in the human body, which necessitates treatments to enable repair, replacement or regeneration of damaged tissue. The treatment normally focuses on transplanting tissue from one site to another in the same patient (an autograft) or from one individual to another (a transplant or allograft). Tissue engineering is an inter-disciplinarily research area, which has wider applications in repair of organs, regeneration, and tissue transplantation. The technology uses synthetic or naturally derived, engineered biomaterials to replace defective or damaged tissues, such as bone, skin, and organs.

    Request a Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/2217

    Key manufacturers in the tissue engineering market are focused on mergers and acquisitions, and partnerships with smaller companies. For instance, in 2017, FUJIFILM Corporation invested US$ 3.7 million in the regenerative medicine venture company NC Medical Research, Inc. with NC Medical granting Fujifilm a stock allocation. Rapid advances in stem cell research with a focus on therapeutic potential for regenerative medicine and other biomedical applications are expected to drive market growth. In combination with tissue engineering, stem cells exhibit growth opportunities in further advancing modern medicine. Although much progress has been made in the field of tissue engineering, further research regarding organ and tissue replacement is necessary. The optimal cell source, scaffold design, and in vitro bioreactors, the use and development of microfabrication technology to create vascularized tissues and organs are still being investigated.

    Browse 21 Market Data Tables and 24 Figures spread through 175 Pages and in-depth TOC on "Tissue Engineering Market, by Material Type (Synthetic, Biological and Others), by Application (Dermal, Orthopedic, Dental, Neurology, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

    To know the latest trends and insights related to tissue engineering market, click the link below:https://www.coherentmarketinsights.com/market-insight/tissue-engineering-market-2217

    Key Takeaways of the Tissue Engineering Market:

    The global tissue engineering market is expected to expand at a CAGR of 11.5% during the forecast period (2018–2026), owing to increasing demand for organ transplantation.
    Among region, Europe is expected to grow at lucrative rate, owing to presence of various public and private organizations focusing on research in tissue engineering field.
    Major players operating in the global tissue engineering market include Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.


    Pareesh Phulkar
    8087996871
    pareesh@coherentmarketinsights.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 17, 2018 ) CANCER SUPPORTIVE CARE MEDICINE Market

    Global CANCER SUPPORTIVE CARE MEDICINE Market 2013-2025, has been prepared on the basis of an in-depth market analysis with from industry experts. The report also includes a debate of the leading players working in this market. In order to calculate the Cancer Supportive Care Medicine market size, the report considers the revenue generated from services provided to end-users such as the pharmaceutical and healthcare companies, medical device manufacturers, contract research organizations, biotechnology companies, and academic and research institutes.

    Request for Sample report at: https://www.reportsweb.com/inquiry&RW00012279302/sample

    The market research report on the Global Cancer Supportive Care Medicine Market by Reports Web is a prominent part of the pharmaceutical and healthcare portfolio and offers insights into the leading trends in the market and potential drivers, including the growth of the Global Cancer Supportive Care Medicine Market Industry. The report undergoes a detailed procedure of data collection methodology and presents an in-depth analysis of all the market segments and sub-segments.

    Any Query Or Specific Discount Requirement? Ask our Industry Expert @ https://www.reportsweb.com/inquiry&RW00012279302/sample

    By Type

    Antiemetic Drugs, Erythropoietin-Stimulating Agents, Granulocyte-Stimulating Agents, Analgesics, Others.

    By Application

    Chemotherapy-Induced Anemia, CINV, Bone Metastasis, Cancer Pain, Others.

    By Company

    Amgen, Helsinn Healthcare, Johnson &Johnson, Merck, F. Hoffmann-La Roche, GlaxoSmithKline, Heron Therapeutics, Kyowa Hakko Kirin, Novartis, TESARO. Some of the major regions included in the research report are:

    North America (United States, Canada and Mexico), Europe (Germany, UK, France, Italy, Russia and Spain etc.), Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.), South America Brazil, Argentina, Colombia and Chile etc.), Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.).

    Competitive Landscape: Global Cancer Supportive Care Medicine Market

    The Global Cancer Supportive Care Medicine Market is highly fragmented and is based on new product launches, product advances, and clinical results of products. Therefore, the leading competitors have made use of different strategies, including new product launches, product advances, clinical trials, assumptions and methodologies, high investments on R&D, market initiatives, joint ventures, mergers & acquisitions, agreements, partnerships, and collaborations, to increase their presence in the market.

    What the report offers:

    1.Market Definition, including the product definition and the identification of key drivers and restraints for the market.
    2.Market analysis for the Global Cancer Supportive Care Medicine Market, with region-specific assessment and competitive landscape on a global and regional basis.
    3.Different factors that are instrumental in changing the market situations, emerging growth opportunities, and identification of key companies, which can affect the market on a global and regional scale.
    4.Thoroughly researched competitive scenario with the profiles of leading competitors along with their strategic initiatives and market shares.
    5.Identification and analysis of the macro and micro factors that affect the Global Cancer Supportive Care Medicine Market on both global and regional scale.
    6.A complete list of major market participants, including the analysis of their present strategies, investments, and key financial data.

    Access Full Report Description, TOC and Table of Figure @ https://www.reportsweb.com/global-and-united-states-cancer-supportive-care-medicine-market-research-by-company-type-and-application-2013-2025


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) The Global Molecular imaging Market, by Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), by Application (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder, Lung Disorder, Bone Disorder, and Others), by End User (Hospital, Diagnostic Imaging Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3.8 billion in 2017, and is projected to exhibit a CAGR of 8.1% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

    Defining disease processes based on their molecular and cellular changes and advances in genomics offer promise for earlier disease detection and molecular prevention in some cases. The field of molecular imaging is adopting these advances and is using various technologies to study disease states and physiology. For instance, optical methods, such as variations of fluorescence imaging, can resolve tissue microstructures or target specific cells using molecular probes. Mass spectrometry offers a new modality for molecular imaging in image-guided surgery by providing detailed information of the chemical makeup of surgical tissue without the need for molecular probes.

    Request a Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/2191

    Molecular imaging is generally used to improve the diagnosis and treatment of lung cancer. In breast cancer, molecular imaging is used to minimize the removal of axillary lymph nodes by determining which nodes are most likely to contain cancer cells. For many gastrointestinal cancers, PET-CT, a molecular imaging technology, is able to identify cancer invasion in the body and assess patient response to chemotherapy. It is also useful in colorectal cancer diagnosis and treatment by providing useful information that directly affects treatment options.

    Browse 27 Market Data Tables and 31 Figures spread through 180 Pages and in-depth TOC on "Molecular Imaging Market, by Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), by Application (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder, Lung Disorder, Bone Disorder, and Others), by End User (Hospital, Diagnostic Imaging Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

    To know the latest trends and insights related to molecular imaging market, click the link below:https://www.coherentmarketinsights.com/market-insight/molecular-imaging-market-2191

    Manufacturers are focused on research and development to integrate advanced medical technologies for in vitro diagnosis. For instance, in 2014, Philips Healthcare received the U.S. FDA approval for spectral imaging system (IQon Spectral CT). The IQon Spectral CT is a leading, new, high standard for medical imaging. As per the study conducted by Radiological Society of North America, in 2013, Philips IQon Spectral CT system exhibited enhanced diagnosis in up to 70% cases as compared to conventional imaging methods.

    With rapid technological advancements, targeted therapy, presymptomatic detection, and personalized medicine are possible in future with the use multimodal molecular imaging. Moreover, researchers are using molecular imaging to identify the strategies for developing new drugs and to design clinical trials to test their effectiveness. Information provided by molecular imaging technologies has the potential to accelerate the drug development and approval process by making it less expensive and more effective.

    Key Takeaways of the Molecular Imaging Market:

    The global molecular imaging market is expected to expand at a CAGR of 8.1% during the forecast period (2018–2026), owing to increasing demand for early disease detection coupled with rising prevalence of cancer and other chronic diseases.
    Among technology, the SPECT segment is expected to generate significant revenue in 2018, owing to advanced radionuclide molecular imaging techniques that are able to evaluate biochemical changes and levels of molecular targets within a living subject.
    Major players operating in the global molecular imaging market include Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, Philips Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems Corporation.


    Pareesh Phulkar
    8087996871
    pareesh@coherentmarketinsights.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) The Global Newborn Screening Market, by Product Type (Assay Kits, Hearing Screening Devices, Mass Spectrometer, and Pulse Oximetry), by Application (Blood Spot Disease, Critical Congenital Cardiac Disease, Maple Syrup Urine Disease, Hearing Disability, Sickle Cell Disease, and Thyroid Disorder), by Test (Blood Test, Cardiac Test, Hearing Test, and Urine Test), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 561.5 million in 2018, and is projected to exhibit a CAGR of 12.4% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

    Newborn screening tests look for developmental, metabolic, and genetic disorders in infants. It allows steps to be taken before development of symptoms. Although, majority of these illnesses are very rare, they can be treated with early diagnosis. Newborn screening includes over 30 conditions and illnesses. Increasing awareness among parents for disease screening is a major factor driving newborn screening market growth. Furthermore, various government and non-government organizations are actively focused on offering better fetal and maternal care. For instance, in June 2018, the American Society of Hematology (ASH) led a campaign to fight sickle cell disease in Africa and urged governments, particularly in sub-Saharan Africa, to invest in newborn screening of the disease.

    Request a Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/2192

    Novel treatments, biomarkers, and technologies are expected to enable various diseases to be considered as potential candidates to be included in New Born Screening (NBS) programs. For instance, new treatments such as Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and gene therapy and new pharmacological drugs have allowed autoimmune diseases to be considered as potential candidates to be included in NBS programs.

    Browse 22 Market Data Tables and 26 Figures spread through 167 Pages and in-depth TOC on "Newborn Screening Market, by Product Type (Assay Kits, Hearing Screening Devices, Mass Spectrometer, and Pulse Oximetry), by Application (Blood Spot Disease, Critical Congenital Cardiac Disease, Maple Syrup Urine Disease, Hearing Disability, Sickle Cell Disease, and Thyroid Disorder), by Test (Blood Test, Cardiac Test, Hearing Test, and Urine Test), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

    To know the latest trends and insights related to new born screening test market, click the link below:
    https://www.coherentmarketinsights.com/market-insight/newborn-screening-market-2192

    Manufacturer in the newborn screening market are focused on developing new test kits and devices in order to diagnose more diseases or disorders at birth. For instance, in February 2018, Sema4, a health information company offering advanced genomic testing, launched Sema4 Natalis, a supplemental newborn screening test designed to detect 193 childhood-onset diseases or disorders.

    Furthermore, several governments are supporting manufacturers to develop new screening tests by relaxing regulations for manufacturing and marketing products. For instance, in February 2017, the U.S. FDA approved marketing of the Seeker System for the screening of four, rare Lysosomal Storage Disorders (LSDs) in newborns. The Seeker system is designed to detect Fabry, Gaucher, Mucopolysaccharidosis Type I (MPS I), and Pompe. It is the first newborn screening test permitted to be marketed by the FDA for these disorders.

    Key Takeaways of the Newborn Screening Market:

    The global newborn screening market is expected to expand at a CAGR of 12.4% during the forecast period (2018 – 2026), owing to increasing government support for newborn screening. According to National Institute of Health, NBS programs across the U.S., screen around four million infants, annually. This public health program detects treatable disorders in newborns, allowing treatment to begin often before symptoms or permanent problems occur.
    Among product type, assay kits segment is expected to hold major revenue share in 2018, owing to increasing number of blood tests being conducted and blood samples stored for future use.
    Major players operating in the global newborn screening market include, Agilent Technologies, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., and ZenTech S.A.


    Pareesh Phulkar
    8087996871
    pareesh@coherentmarketinsights.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 17, 2018 ) The Global Orthokeratology Market, by Lens Type (Fluorosilicone Acrylate, Silicone Acrylate, Balafilcon, and Oprifocon A), by Application (Myopia, Hyperopia, Presbyopia, and Astigmatism), by Distribution Channel (Hospitals, Optometry Clinics, and Ophthalmology Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 37.6 million in 2017, and is projected to exhibit a CAGR of 7.0% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

    Orthokeratology improves blurry vision without need of glasses, contact lenses, and corneal reshaping surgery such as photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK). Moreover, it is cost-effective as compared to laser surgeries. Orthokeratology contact lenses are gaining significant traction with the method of slowing the progression of myopia in children. It is an alternative method to correct refractive errors using custom-designed rigid lenses, which modify the curvature of cornea for short duration. In recent years, the most common clinical application of ortho-k is for the reduction of myopia through corneal flattening.

    Request a Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/2193

    According to the Association of Optometrists, most orthokeratology lenses are suitable for myopes between -1.00 and -4.00 and Cylinder value (cyls) to 1.50 and 0.75. Latest available product in market can correct high levels of myopia, potentially up to -10.00, and cyls to 2.50. In 2016, GP Specialists developed an advanced ortho-k lens iSee design shown to correct patients with high myopic powers. OrthoK in general is a safe option for myopia correction and retardation. However, the long-term success of the treatment depends on a combination of multiple factors including proper fitting of the lenses, rigorous compliance to lens use and care regimen, adherence to routine follow-ups, and timely and appropriate treatments to complications.

    Browse 22 Market Data Tables and 26 Figures spread through 154 Pages and in-depth TOC on "Orthokeratology Market, by Lens Type (Fluorosilicone Acrylate, Silicone Acrylate, Balafilcon, and Oprifocon A), by Application (Myopia, Hyperopia, Presbyopia, Astigmatism), by Distribution Channel (Hospitals, Optometry Clinics and Ophthalmology Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

    To know the latest trends and insights related to orthokeratology market, click the link below:https://www.coherentmarketinsights.com/market-insight/orthokeratology-market-2193

    Manufacturers in orthokeratology market are majorly investing in development of progressive technologies and expert resources. For instance, in 2018, Euclid Systems Corporation introduced Emeraldä163 Ortho-K contact lens, featuring a hyper Dk lens material with outstanding oxygen transmissibility for optimal ocular health. Moreover, Paragon Vision Sciences’ Corneal Refractive Therapy (Paragon Z CRT) launched in 2002, and Bausch and Lomb’s Vision Shaping Treatment (VST) lenses launched in 2004, are the two major products available in the market so far.

    Key Takeaways of the Orthokeratology Market:

    The global orthokeratology market is expected to expand at a CAGR of 7.0% during the forecast period (2018–2026), owing to increasing cases of myopia worldwide.
    Among region, the Asia Pacific is expected witness growth at highest rate, owing to increasing prevalence of myopia in East Asian countries including China, Japan, and South Korea among others.
    Major players operating in the global orthokeratology market include Autek China, Alpha Corporation, Bausch and Lomb Inc., Euclid Systems, E & E Optics, Essilor International S.A., GP Specialists, Paragon Vision Sciences, Procornea, and Taiwan Macro Vision Corporation.


    Pareesh Phulkar
    8087996871
    pareesh@coherentmarketinsights.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) This study categorizes the global Liquid Chromatography Detectors breakdown data by manufacturers, region, type and application. It also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities & challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. As per this report Global Liquid Chromatography Detectors market size will increase to XX Million US$ by 2025, from XX Million US$ in 2017, at a CAGR of XX% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Liquid Chromatography Detectors.
    Access More Details about this Report at: https://www.themarketreports.com/report/global-liquid-chromatography-detectors-market-insights-forecast-to-2025

    Key companies profiled in Global Liquid Chromatography Detectors Market Report are Agilent, Thermo Fisher, Shimadzu, Waters, Showa Denko K.K., PerkinElmer, Gl Sciences, Bio-rad, Metrohm, Jasco and more in terms of capacity, production, value, price and market share of Liquid Chromatography Detectors in global market.
    Liquid Chromatography Detectors Breakdown Data by Type
    • UV-Visible Detectors
    • Refractive Index Detectors
    • ELSD Detectors
    • Fluorescence Detectors
    • Other
    Liquid Chromatography Detectors Breakdown Data by Application
    • Liquid Chromatography
    • HPLC
    • UHPLC
    Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/1303111

    Table of Contents
    1 Study Coverage
    2 Executive Summary
    3 Market Size by Manufacturers
    4 Liquid Chromatography Detectors Production by Regions
    5 Liquid Chromatography Detectors Consumption by Regions
    6 Market Size by Type
    7 Market Size by Application
    8 Manufacturers Profiles
    9 Production Forecasts
    10 Consumption Forecast
    11 Upstream, Industry Chain and Downstream Customers Analysis
    12 Opportunities & Challenges, Threat and Affecting Factors
    13 Key Findings
    14 Appendix
    Inquire for more details about this report at: https://www.themarketreports.com/report/ask-your-query/1303111


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) Global Medical Ventilator Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Medical Ventilator. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Medical Ventilator market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Medical Ventilator Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-medical-ventilator-market-research-report-2018

    With this Medical Ventilator Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Resmed, Medtronic, Bd (Carefusion), Philips Healthcare, Ge Healthcare, Invacare, Teijin Pharma, Fisher & Paykel, Drager Medical, Devilbiss, Event Medical and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1010171

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Medical Ventilator Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1010171

    List of Chapters:
    1 Medical Ventilator Market Overview
    2 Global Medical Ventilator Market Competitions by Manufacturers
    3 Global Medical Ventilator Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Medical Ventilator Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Medical Ventilator Production, Revenue (Value), Price Trend by Type
    6 Global Medical Ventilator Market Analysis by Application
    7 Global Medical Ventilator Manufacturers Profiles/Analysis
    8 Medical Ventilator Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Medical Ventilator Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) This study categorizes the global Nicotine Patch breakdown data by manufacturers, region, type and application. It also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities & challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. As per this report Global Nicotine Patch market size will increase to XX Million US$ by 2025, from XX Million US$ in 2017, at a CAGR of XX% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Nicotine Patch.
    Access More Details about this Report at: https://www.themarketreports.com/report/global-nicotine-patch-market-insights-forecast-to-2025

    Key companies profiled in Global Nicotine Patch Market Report are Gsk, McNeil (Johnson&Johnson), Novartis, Cigna, Revolymer, Yesmoke, Habitrol and more in terms of capacity, production, value, price and market share of Nicotine Patch in global market.
    Nicotine Patch Breakdown Data by Type
    • 16-hour patches
    • 24-hour patches
    Nicotine Patch Breakdown Data by Application
    • Male
    • Female
    Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/1238806

    Table of Contents
    1 Study Coverage
    2 Executive Summary
    3 Market Size by Manufacturers
    4 Nicotine Patch Production by Regions
    5 Nicotine Patch Consumption by Regions
    6 Market Size by Type
    7 Market Size by Application
    8 Manufacturers Profiles
    9 Production Forecasts
    10 Consumption Forecast
    11 Upstream, Industry Chain and Downstream Customers Analysis
    12 Opportunities & Challenges, Threat and Affecting Factors
    13 Key Findings
    14 Appendix
    Inquire for more details about this report at: https://www.themarketreports.com/report/ask-your-query/1238806


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 17, 2018 ) This study categorizes the global Pre-Workout Supplements breakdown data by manufacturers, region, type and application. It also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities & challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. As per this report Global Pre-Workout Supplements market size will increase to XX Million US$ by 2025, from XX Million US$ in 2017, at a CAGR of XX% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Pre-Workout Supplements.
    Access More Details about this Report at: https://www.themarketreports.com/report/global-pre-workout-supplements-market-insights-forecast-to-2025

    Key companies profiled in Global Pre-Workout Supplements Market Report are Nutrex, Muscletech, Cellucor, Bsn, Gat Sport, Animal, Bpi Sports, Mhp, Musclepharm, San, Man Sports, Finaflex, Prosupps, Ronnie Coleman Signature Series, Redcon1, Allmax Nutrition, Optimum Nutrition, Eflow Nutrition, Magnum Nutraceuticals, Efx Sports, Scivation, Beast Sports Nutrition, Mts Nutrition, Grenade, Cobra Labs and more in terms of capacity, production, value, price and market share of Pre-Workout Supplements in global market.
    Pre-Workout Supplements Breakdown Data by Type
    • Creatine-Free
    • Stimulant-Free
    Pre-Workout Supplements Breakdown Data by Application
    • Supermarkets/Hypermarkets
    • Drug Stores
    • Convenience Stores
    • Other
    Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/1302913

    Table of Contents
    1 Study Coverage
    2 Executive Summary
    3 Market Size by Manufacturers
    4 Pre-Workout Supplements Production by Regions
    5 Pre-Workout Supplements Consumption by Regions
    6 Market Size by Type
    7 Market Size by Application
    8 Manufacturers Profiles
    9 Production Forecasts
    10 Consumption Forecast
    11 Upstream, Industry Chain and Downstream Customers Analysis
    12 Opportunities & Challenges, Threat and Affecting Factors
    13 Key Findings
    14 Appendix
    Inquire for more details about this report at: https://www.themarketreports.com/report/ask-your-query/1302913


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

older | 1 | .... | 1082 | 1083 | (Page 1084) | 1085 | 1086 | .... | 1118 | newer